The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in sales , its exclusivity period created a deluge of knock-off https://janegjgp054671.tribunablog.com/sildenafil-and-pharma-a-risky-opportunity-55720739